Abstract
A glycosylated hemoglobin (HbA1) test was used to evaluate the role of dialysate glucose in the development of carbohydrate intolerance and hyperlipidemia in chronic hemodialysis patients and chronic peritoneal dialysis patients. HbA1 levels were significantly elevated in all groups of patients. HbA1 levels were not ameliorated with 8 weeks of glucose-free hemodialysis. There was no correlation between HbA1 and serum glucose, triglycerides, or cholesterol.
Thus, HbA1 elevation cannot be explained solely by glucose reabsorption from dialysate. This test is helpful in the detection of carbohydrate intolerance, but its usefulness in evaluation of hyperlipidemia of dialysis patients is uncertain.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Trivelli, L. A., Ranney, H. M., Lai, H. T.: Hemoglobin components in patients with diabetes mellitus.N. Engl. J. Med., 284, 353 (1971).
Peterson, C. M., Jones, R. L.: Minor hemoglobins, diabetic “control”, and diseases of postsynthetic protein modification (editorial).Ann. Intern. Med., 87, 489 (1977).
Bunn, H. F., Gabbay, K. H., Gallop, P. M.: The glycosylation of hemoglobin: Relevance to diabetes mellitus.Science, 200, 21 (1978).
Gabbay, K. H., Hasty, K., Breslow, J. L., Ellison, R. C., Bunn, H. F., Gallop, P. M.: Glycosylated hemoglobins and long-term blood glucose control in diabetes mellitus.J. Clin. Endocrinol. Metab., 44, 859 (1977).
Dunn, P. J., Cole, R. A., Soeldner, J. S., Gleason, R. E.: Reproducibility of hemoglobin A1c and sensitivity to various degrees of glucose intolerance.Ann. Intern. Med., 91, 390 (1979).
Peterson, C. M., Koenig, R. J., Jones, R. L., Sandek, C. D., Cerami, A.: Correlation of serum triglyceride levels and hemoglobin A1c concentrations in diabetes mellitus.Diabetes, 26, 507 (1977).
Casparie, A. F., Miedema, K.: Glycosylated haemoglobin in diabetes and renal failure.Lancet, 2, 758 (1977).
Dandona, P., Freedman, D., Moorhead, J. F.: Glycosylated haemoglobin in chronic renal failure.Brit. Med. J., 2, 1183 (1979).
Schernthaner, G., Stumvoll, K. H., Muller, M. M.: Glycosylated haemoglobin in chronic renal failure.Lancet, 1, 774 (1979).
Zawada, E. T. Jr., Virji, A.: Glycosylated hemoglobin test in diabetic and non-diabetic hemodialysis patients.Dialysis and Transplantation, 9, 360 (1980).
Barthelmai, W., Czok, R.: Enzymatische Bestimmungen der Glucose in Blut, Liquor und Harn.Klin. Wschr., 40, 585 (1962).
Rautela, G. S., Hall, R. G. Jr., Bekiesz, C. L., Wermus, G. R.: A kinetic method for rapid and automatic measurement of triglycerides in biological fluids.Clin. Chem., 20, 857 (1974).
Allain, C. C., Poon, L. S., Chan, C. S. G., Richmond, W., Fu, P. C.: Enzymatic determination of total serum cholesterol.Clin. Chem., 20, 470 (1974).
Reaven, G. M., Weisinger, J. R., Swenson, R. S.: Insulin and glucose metabolism in renal insufficiency.Kidney Int., 6, S1, 63 (1974).
Westervelt, F. B., Glucose intolerance in the hemodialyzed patient: A brief overview.Kidney Int., 6, S1, 70 (1974).
Lowrie, E. J., Soeldner, J. S., Hampers, C. L., Merrill, J. P.: Glucose metabolism and insulin secretion in uremic prediabetic and normal subjects.J. Lab. Clin. Med., 76, 603 (1970).
Bagdade, J. D.: Uremic lipemia. An unrecognized abnormality in triglyceride production and removal.Arch. Intern. Med., 126, 875 (1970).
Henck, C. C., Ritz, E.: Hyperlipoproteinemia in renal insufficiency.Nephron, 25, 1 (1980).
Lindner, A., Chazze, B., Sherrard, D. J., Scribner, B. H.: Accelerated atherosclerosis in prolonged maintenance hemodialysis.N. Engl. J. Med., 290, 697 (1974).
Wathen, R., Keshaviah, P., Hommeyer, P., Cadwell, K., Comty, C.: Role of dialysate glucose in preventing gluconeogenesis during hemodialysis.Trans. Am. Soc. Artif. Intern. Organs, 23, 393 (1977).
Nolph, K. D., Rosenfeld, P. S., Powell, J. T., Danforth, E. Jr.: Peritoneal glucose transport and hyperglycemia during peritoneal dialysis.Am. J. Med. Sci. 259, 272 (1970).
Andersson, G., Berquist-Poppen, M., Bergstrom J., Collste, L. G., Hultman, E.: Glucose absorption from the dialysis fluid during peritoneal dialysis.Scand. J. Urol. Nephrol., 5, 77 (1971).
Rorke, S. J., Davidson, W. D., Guo, S. S., Morin, R. J.: Metabolic fate of14C-acetate during dialysis.Proc. Eur. Dial. Transpl. Assoc., 13, 394 (1976).
Hubner, W., Sieberth, U. G., Diemer, A., Finke, K., Prange, E.: Effect of regular hemodialysis with glucose and glucose free dialysate on hyperlipidemia.Proc. Eur. Dial. Transpl. Assoc., 8, 174 (1971).
Dombeck, D. H., Lindholm, D. D., Vieira, J. A.: Lipid metabolism in uremia and the effects of dialysate glucose and oral androgen therapy.Trans. Am. Soc. Artif. Intern. Organs, 19, 150 (1973).
Swamy, A. P., Cestero, R. V. M., Campbell, R. G., Freeman, R. B.: Long-term effect of dialysate glucose on the lipid levels of maintenance hemodialysis patients.Trans. Am. Soc. Artif. Intern. Organs, 22, 54 (1976).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hirszel, P., Galen, M.A., Happe, T. et al. Glycosylated hemoglobin in patients treated by chronic dialysis. International Urology and Nephrology 13, 185–191 (1981). https://doi.org/10.1007/BF02082063
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02082063